Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease

1994/06/01 by E. H. Corder, Elizabeth H. Corder, Ann M. Saunders +20 · 16 citations
Medicine · Neuroscience · #Alzheimer's disease research and treatments #Cholinesterase and Neurodegenerative Diseases #Nuclear Receptors and Signaling

paper · doi:10.1038/ng0694-180

crossref issued 1994/06/01 · crossref published 1994/06/01 · crossref published-print 1994/06/01 · openalex publication_date 1994/06/01 · crossref created 2004/08/18 · crossref deposited 2023/05/18 · openalex created_date 2025/10/10 · crossref indexed 2026/07/29 · openalex updated_date 2026/08/01

Citations

• Centre d'Etude du polymorphisme humain (CEPH): Collaborative genetic mapping of the human genome
• Genetic Linkage Evidence for a Familial Alzheimer's Disease Locus on Chromosome 14
• Gene Dose of Apolipoprotein E Type 4 Allele and the Risk of Alzheimer's Disease in Late Onset Families
• Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease
• Diagnosis of Alzheimer's Disease

Cited by

• Apolipoprotein E isoforms and apolipoprotein AI protect from amyloid precursor protein carboxy terminal fragment‐associated cytotoxicity
• El espejismo de la arquitectura asturiana
• APOE ε4 is associated with longer telomeres, and longer telomeres among ε4 carriers predicts worse episodic memory
• Cognitive change and the APOE ɛ4 allele
• Effects of Age, Sex, and Ethnicity on the Association Between Apolipoprotein E Genotype and Alzheimer Disease
• The neurobiology of apolipoproteins and their receptors in the CNS and Alzheimer's disease
• Apolipoprotein E and Alzheimer disease.
• The apolipoprotein E gene, attention, and brain function.
• Better Memory and Neural Efficiency in Young Apolipoprotein E 4 Carriers
• Morphological, Biochemical, and Genetic Support for an Apolipoprotein E Effect on Microtubular Metabolisma
• Impact of Apolipoprotein E on Alzheimer’s Disease
• Changes in Apolipoprotein E Expression in Response to Dietary and Pharmacological Modulation of Cholesterol
• The genetic architecture of Alzheimer's disease: beyond APP, PSENs and APOE
• Apolipoprotein E 2 genotype delays onset of dementia with Lewy bodies in a Norwegian cohort
• Apolipoprotein E [wikipedia]
• Behavioural genetics [wikipedia]